MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
AtriCure Long-Term Debt 2011-2025 | ATRC
Long-term debt is a financial obligation of a company or an individual with a repayment period exceeding one year from the date it arises. In accounting, such obligations are recorded under the "long-term liabilities" section.
Main characteristics:- Term exceeds 12 months
- Can take the form of bonds, bank loans, credit lines, leasing, or loans from affiliated parties
- Repaid through regular payments (interest and/or principal) over several years
- Investment in development
Allows financing of large projects — new factories, production lines, innovative developments — without diverting working capital. - Smoothing of cash flows
A long-term payment schedule facilitates budget planning and reduces short-term financial risks. - Optimization of capital structure
A combination of equity and borrowed capital can reduce the average cost of business financing.
A high level of long-term debt may indicate that a company heavily relies on borrowed funds. This increases risks, especially in conditions of rising interest rates or declining profits. However, a moderate level of debt can signal a sound growth strategy — for example, the company takes a loan to expand its business.
If a company uses borrowed funds effectively (e.g., invests in profitable projects), this can lead to profit growth and, consequently, an increase in stock value. An investor evaluates whether the investments made using debt are paying off.
It is important to monitor whether the company can regularly pay interest and repay the principal. Payment difficulties can lead to reduced dividends, a drop in stock value, and even bankruptcy.
Examples of long-term debt:- Mortgage loans for property purchases
- Corporate bonds issued by a company to raise capital
- Project financing — long-term loans for building or expanding production facilities
- Leasing obligations for equipment or transport
Annual Long-Term Debt AtriCure
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.9 M | 60.6 M | 56.8 M | 59.7 M | 53.4 M | 59.6 M | 35.6 M | 24.1 M | 23.9 M | - | 74 K | 4.41 M | 6.41 M | 4.93 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 61.9 M | 74 K | 34.7 M |
Quarterly Long-Term Debt AtriCure
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 61.9 M | 60.6 M | 42.2 M | 47 M | 51.9 M | 56.8 M | 60.1 M | - | 59.8 M | 59.7 M | 56.4 M | 43.7 M | 48.6 M | 53.4 M | 53.4 M | 53.4 M | 53.4 M | 59.6 M | 59.6 M | 59.6 M | 59.6 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 24.1 M | 24.1 M | 24.1 M | 24.1 M | 23.9 M | 23.9 M | 23.9 M | 23.9 M | - | - | - | - | 74 K | 55 K | 65 K | 69 K | 4.41 M | 4.41 M | 4.41 M | 4.41 M | 6.41 M | 6.41 M | 6.41 M | 6.41 M | 4.93 M | 4.93 M | 4.93 M | 4.93 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 61.9 M | 55 K | 34.1 M |
Long-Term Debt of other stocks in the Medical instruments industry
| Issuer | Long-Term Debt | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
5 M | $ 24.56 | 0.7 % | $ 1.13 B |  USA |
 |
Baxter International
BAX
|
13.2 B | $ 19.52 | 1.93 % | $ 9.96 B | USA |
 |
Becton, Dickinson and Company
BDX
|
17.6 B | $ 200.48 | -0.23 % | $ 57.7 B | USA |
 |
Luminex Corporation
LMNX
|
203 M | - | - | $ 1.75 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
452 K | $ 4.68 | 0.21 % | $ 94.4 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
24.7 M | - | - | $ 955 M | USA |
 |
Cantel Medical Corp.
CMD
|
1.05 B | - | -1.18 % | $ 3.4 B | USA |
 |
CRH Medical Corporation
CRHM
|
70.6 M | - | - | $ 282 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
1.66 B | - | -0.05 % | $ 10.3 B | USA |
 |
Harvard Bioscience
HBIO
|
30.7 M | $ 0.71 | -4.45 % | $ 30.1 M | USA |
 |
Varian Medical Systems, Inc.
VAR
|
288 M | - | -0.02 % | $ 16.3 B | USA |
 |
ICU Medical
ICUI
|
1.53 B | $ 148.28 | -0.1 % | $ 3.62 B | USA |
 |
iRhythm Technologies
IRTC
|
74.6 M | $ 170.21 | 0.82 % | $ 5.31 B | USA |
 |
Alcon
ALC
|
3.95 B | $ 79.15 | 0.43 % | $ 40.4 B |  Schweiz |
 |
electroCore
ECOR
|
537 K | $ 4.85 | 2.11 % | $ 26.7 K | USA |
 |
Repro Med Systems
KRMD
|
317 K | $ 5.8 | 0.35 % | $ 264 M | USA |
 |
AngioDynamics
ANGO
|
5.8 M | $ 13.42 | 2.13 % | $ 548 M | USA |
 |
The Cooper Companies
COO
|
2.46 B | $ 81.36 | -0.88 % | $ 16.2 B | USA |
 |
LeMaitre Vascular
LMAT
|
168 M | $ 83.04 | -1.14 % | $ 1.86 B | USA |
 |
Glaukos Corporation
GKOS
|
70.5 M | $ 111.73 | 2.6 % | $ 5.41 B | USA |
 |
Masimo Corporation
MASI
|
728 M | $ 137.35 | -0.72 % | $ 7.32 B | USA |
 |
Haemonetics Corporation
HAE
|
921 M | $ 80.24 | -3.89 % | $ 4.04 B | USA |
 |
InfuSystem Holdings
INFU
|
33.2 M | $ 9.22 | -0.27 % | $ 190 M | USA |
 |
Merit Medical Systems
MMSI
|
730 M | $ 86.49 | -0.24 % | $ 5.04 B | USA |
 |
Isoray
ISR
|
1.68 M | - | 0.03 % | $ 108 M | USA |
 |
Intuitive Surgical
ISRG
|
112 M | $ 559.7 | 3.2 % | $ 199 B | USA |
 |
OraSure Technologies
OSUR
|
113 K | $ 2.49 | - | $ 185 M | USA |
 |
Microbot Medical
MBOT
|
40 K | $ 2.23 | -7.65 % | $ 22.7 M |  Israel |
 |
Milestone Scientific
MLSS
|
54.7 K | $ 0.36 | -7.4 % | $ 28.7 M | USA |
 |
Nephros
NEPH
|
1.39 M | $ 4.98 | -0.8 % | $ 51.7 M | USA |
 |
NeuroMetrix
NURO
|
92.5 K | - | 5.05 % | $ 9.02 M | USA |
 |
ResMed
RMD
|
765 M | $ 251.67 | -0.27 % | $ 36.8 B | USA |
 |
Envista Holdings Corporation
NVST
|
1.28 B | $ 22.07 | 0.46 % | $ 3.8 B | USA |
 |
Pro-Dex
PDEX
|
15.4 M | $ 44.0 | 1.43 % | $ 145 M | USA |
 |
STAAR Surgical Company
STAA
|
34.8 M | $ 23.49 | -2.65 % | $ 1.15 B | USA |
 |
STERIS plc
STE
|
1.92 B | $ 253.98 | 0.82 % | $ 25 B | USA |
 |
Stereotaxis
STXS
|
5.06 M | $ 2.35 | -1.05 % | $ 190 M | USA |
 |
Pulse Biosciences
PLSE
|
8.09 M | $ 14.04 | -1.4 % | $ 674 M | USA |
 |
Predictive Oncology
POAI
|
1.56 M | - | - | $ 32.4 M | USA |
 |
Repligen Corporation
RGEN
|
510 M | $ 160.09 | 1.72 % | $ 8.92 M | USA |
 |
Utah Medical Products
UTMD
|
396 K | $ 57.54 | -0.96 % | $ 209 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.59 B | $ 11.43 | -1.21 % | $ 2.32 B | USA |
 |
Retractable Technologies
RVP
|
900 K | $ 0.84 | 1.99 % | $ 25.1 M | USA |
 |
Teleflex Incorporated
TFX
|
1.56 B | $ 126.88 | 0.17 % | $ 5.94 B | USA |
 |
West Pharmaceutical Services
WST
|
203 M | $ 271.82 | 1.6 % | $ 19.8 B | USA |